Search Results 1011-1020 of 16636 for Psychogenic
The purpose of this study is to compare the safety and effectiveness of the PMX cartridge (Toraymyxin) based on mortality at 28 days in patients with septic ...
Li J, Ardon AE, Johnson RL, Gillespie N, Lai Y, Ouanes JP, Shilling AM, Tokita HK, Ledford CK, Wilson SH. Limited evidence for anesthesia and analgesia for ...
This phase II trial studies how well daunorubicin hydrochloride, cytarabine, and nilotinib work in treating patients newly diagnosed with acute myeloid leukemia ...
Differentiating ictal panic with low-grade temporal lobe tumors from psychogenic panic attacks. J Clin Psychiatry. 2013 Nov; 74 (11):1071-5. View PubMed ...
Dawn Lenhardt's life changed when she was diagnosed with cancer. But, she learned a type of treatment without losing her hair was available, allowing her to ...
The phase 1 primary objectives of this study are to assess the safety profile, characterize pharmacokinetics (PK) and determine the dosing schedule, maximum ...
About this study. We are testing this hypothesis through three phases for which we have developed three protocols. In this phase, with this protocol, ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
Liu K, Valentini C, Limage K, Moss H, Whitlark A, Cheng T, Bair H, Marous C, Flanders A, Rosen M, Nyquist G, Toskala E, Shebaclo K, Watson A, Rabinowitz M.
The purpose of this study is to assess the safety and tolerability of midodrine in patients with Hepatopulmonary Syndrome (HPS). Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.